Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Marchesi

Showing results (61-70 of 141) with videos related to

Pageof 15
Sort By:
Blood Reviews|June 25, 2026
Antibacterial, antifungal and antiviral prophylaxis and vaccination strategies in adult patients with acute myeloid and promyelocytic leukemia: An expert panel consensus from the GIMEMA groupFrancesco Marchesi, Corrado Girmenia, Enrico Maria Trecarichi, et al.
British Journal of Haematology|July 21, 2025
A predictive serum miRNA signature impacts diffuse large B-cell lymphoma cell viability via inhibition of EGLN1 and TXNRD1 regulators of ferroptosisGiulia Regazzo, Giulia Vari, Francesco Marchesi, et al.
Microbiology Spectrum|August 18, 2021
The Impact of Bacterial Biofilms on End-Organ Disease and Mortality in Patients with Hematologic Malignancies Developing a Bloodstream InfectionEnea Gino Di Domenico, Francesco Marchesi, Ilaria Cavallo, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 20, 2016
Flow cytometry remission by Ig light chains ratio is a powerful marker of outcome in multiple myeloma after tandem autologous transplant: a real-life studyIole Cordone, Francesco Marchesi, Serena Masi, et al.
The Journal of Clinical Investigation|November 27, 2007
Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in miceDanielle C Shing, Maurizio Trubia, Francesco Marchesi, et al.
Plos One|March 23, 2013
The Polo-Like Kinase 1 (PLK1) inhibitor NMS-P937 is effective in a new model of disseminated primary CD56+ acute monoblastic leukaemiaAlessia Casolaro, Josee Golay, Clara Albanese, et al.
Cell|August 2, 2016
UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the ProteasomeRoland Hjerpe, John S Bett, Matthew J Keuss, et al.
British Journal of Haematology|July 28, 2021
MiR-22, a serum predictor of poor outcome and therapy response in diffuse large B-cell lymphoma patientsFederica Rinaldi, Francesco Marchesi, Francesca Palombi, et al.
Mycoses|June 13, 2020
Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxisBrunella Posteraro, Elena De Carolis, Marianna Criscuolo, et al.
British Journal of Haematology|October 15, 2020
Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective studyGessica Marchesini, Gianpaolo Nadali, Davide Facchinelli, et al.
Pageof 15

Showing results (61-70 of 141) with videos related to

Sort By:
Pageof 15
Blood Reviews|June 25, 2026
Antibacterial, antifungal and antiviral prophylaxis and vaccination strategies in adult patients with acute myeloid and promyelocytic leukemia: An expert panel consensus from the GIMEMA groupFrancesco Marchesi, Corrado Girmenia, Enrico Maria Trecarichi, et al.
British Journal of Haematology|July 21, 2025
A predictive serum miRNA signature impacts diffuse large B-cell lymphoma cell viability via inhibition of EGLN1 and TXNRD1 regulators of ferroptosisGiulia Regazzo, Giulia Vari, Francesco Marchesi, et al.
Microbiology Spectrum|August 18, 2021
The Impact of Bacterial Biofilms on End-Organ Disease and Mortality in Patients with Hematologic Malignancies Developing a Bloodstream InfectionEnea Gino Di Domenico, Francesco Marchesi, Ilaria Cavallo, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 20, 2016
Flow cytometry remission by Ig light chains ratio is a powerful marker of outcome in multiple myeloma after tandem autologous transplant: a real-life studyIole Cordone, Francesco Marchesi, Serena Masi, et al.
The Journal of Clinical Investigation|November 27, 2007
Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in miceDanielle C Shing, Maurizio Trubia, Francesco Marchesi, et al.
Plos One|March 23, 2013
The Polo-Like Kinase 1 (PLK1) inhibitor NMS-P937 is effective in a new model of disseminated primary CD56+ acute monoblastic leukaemiaAlessia Casolaro, Josee Golay, Clara Albanese, et al.
Cell|August 2, 2016
UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the ProteasomeRoland Hjerpe, John S Bett, Matthew J Keuss, et al.
British Journal of Haematology|July 28, 2021
MiR-22, a serum predictor of poor outcome and therapy response in diffuse large B-cell lymphoma patientsFederica Rinaldi, Francesco Marchesi, Francesca Palombi, et al.
Mycoses|June 13, 2020
Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxisBrunella Posteraro, Elena De Carolis, Marianna Criscuolo, et al.
British Journal of Haematology|October 15, 2020
Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective studyGessica Marchesini, Gianpaolo Nadali, Davide Facchinelli, et al.
Pageof 15